- Home
- KROS vs MPB Comparison
KROS vs MPB Comparison
Compare KROS & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- MPB
- Stock Information
- Founded
- KROS 2015
- MPB 1868
- Country
- KROS United States
- MPB United States
- Employees
- KROS N/A
- MPB N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- MPB Major Banks
- Sector
- KROS Health Care
- MPB Finance
- Exchange
- KROS Nasdaq
- MPB Nasdaq
- Market Cap
- KROS 565.0M
- MPB 691.1M
- IPO Year
- KROS 2020
- MPB N/A
- Fundamental
- Price
- KROS $15.62
- MPB $30.71
- Analyst Decision
- KROS Buy
- MPB Buy
- Analyst Count
- KROS 14
- MPB 2
- Target Price
- KROS $20.56
- MPB $34.50
- AVG Volume (30 Days)
- KROS 412.4K
- MPB 82.5K
- Earning Date
- KROS 11-05-2025
- MPB 10-22-2025
- Dividend Yield
- KROS N/A
- MPB 2.60%
- EPS Growth
- KROS N/A
- MPB N/A
- EPS
- KROS 0.47
- MPB 2.30
- Revenue
- KROS $232,844,000.00
- MPB $191,454,000.00
- Revenue This Year
- KROS $5,998.31
- MPB $24.57
- Revenue Next Year
- KROS N/A
- MPB $12.23
- P/E Ratio
- KROS $33.74
- MPB $13.35
- Revenue Growth
- KROS 85820.30
- MPB 13.34
- 52 Week Low
- KROS $9.12
- MPB $22.50
- 52 Week High
- KROS $72.37
- MPB $33.87
- Technical
- Relative Strength Index (RSI)
- KROS 57.13
- MPB 66.81
- Support Level
- KROS $15.34
- MPB $29.94
- Resistance Level
- KROS $15.85
- MPB $30.44
- Average True Range (ATR)
- KROS 0.45
- MPB 0.60
- MACD
- KROS -0.02
- MPB -0.02
- Stochastic Oscillator
- KROS 57.08
- MPB 79.70
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.